tiprankstipranks
ThermoGenesis Holdings (THMO)
NASDAQ:THMO

ThermoGenesis Holdings Stock Analysis & Ratings

THMO Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$0.09 - $2.50
Previous Close$0.23
Volume2.89M
Average Volume (3M)2.70M
Market CapN/A
Enterprise ValueN/A
P/E Ratio-0.2
Beta1.70
Next EarningsAug 17, 2022
EPS ForecastN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
1Y Price TargetN/A
Smart ScoreN/A


Financials

Yearly

P/E Ratio Range

The price to earnings ratio. This is used by investors to assess a stock’s market price relative to its earnings.

---

Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

Product Monthly Users

Sorry, No Data Available
There is no website visitor data available for this stock.

---

THMO FAQ

What was ThermoGenesis Holdings’s price range in the past 12 months?
ThermoGenesis Holdings lowest stock price was $0.09 and its highest was $2.50 in the past 12 months.
    What is ThermoGenesis Holdings’s market cap?
    Currently, no data Available
    What is ThermoGenesis Holdings’s price target?
    Currently, no data Available
    What do analysts say about ThermoGenesis Holdings?
    Not enough analysts have published a price target to provide an average price target.
    When is ThermoGenesis Holdings’s upcoming earnings report date?
    ThermoGenesis Holdings’s upcoming earnings report date is Aug 17, 2022 which is in 9 days.
      How were ThermoGenesis Holdings’s earnings last quarter?
      ThermoGenesis Holdings released its earnings results on May 19, 2022. The company reported -$0.16 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.16.
        Is ThermoGenesis Holdings overvalued?
        According to Wall Street analysts ThermoGenesis Holdings’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does ThermoGenesis Holdings pay dividends?
          ThermoGenesis Holdings does not currently pay dividends.
          What is ThermoGenesis Holdings’s EPS estimate?
          ThermoGenesis Holdings’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does ThermoGenesis Holdings have?
          ThermoGenesis Holdings has 31,321,362 shares outstanding.
            What happened to ThermoGenesis Holdings’s price movement after its last earnings report?
            ThermoGenesis Holdings reported an EPS of -$0.16 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -10.526%.
              Which hedge fund is a major shareholder of ThermoGenesis Holdings?
              Currently, no hedge funds are holding shares in THMO

              ---

              ThermoGenesis Holdings Stock Analysis

              Smart Score
              N/A
              Not Ranked
              1
              2
              3
              4
              5
              6
              7
              8
              9
              10
              Price Target
              No data currently available
              This stock does not have enough of the key information we need to rate it accurately. Smart Score is calculated for stocks traded in Nasdaq, NYSE, TSE and LSE with a market cap above $30M and average 3 months trading volume above $30K.
              Learn more about TipRanks Smart Score

              Company Description

              ThermoGenesis Holdings

              ThermoGenesis Holdings, Inc. engages in the research, development, commercialization and marketing of automated technologies for cell-based therapies for use in regenerative medicine. It operates through the following segments: Device and Clinical Development. The Device segment includes development and commercialization of automated systems that provide good manufacturing practice, clinical grade cell-banking, cell-processing and cell-based therapeutics. The Clinical Development segment develops autologous stem cell-based therapeutics that address significant unmet medical needs for the vascular, cardiology, and orthopedic markets. The company was founded by Philip H. Coelho in 1986 and is headquartered in Rancho Cordova, CA.

              ---
              Similar Stocks
              Company
              Price & Change
              Follow
              Abbott Labs
              Intuitive Surgical
              Stryker
              Becton Dickinson
              Edwards Lifesciences

              Popular Stocks

              ---
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis